From February 6, 2022 to March 31, 2022, the company has repurchased 680,000 shares, representing 0.21% for CNY 49.85 million. With this, the company has completed the repurchase of 680,000 shares, representing 0.21% for CNY 49.85 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.5 CNY | -0.38% | -8.10% | -2.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.52% | 1.72B | |
+10.91% | 226B | |
+14.77% | 198B | |
+19.61% | 142B | |
+30.32% | 111B | |
+2.09% | 65.26B | |
+16.54% | 54.36B | |
+4.96% | 50.94B | |
+9.58% | 44.8B | |
+4.32% | 36.8B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.